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STUDIES ON THE COAGULASE-REACTING FACTOR:
1. THE REACTION OF STAPHYLOCOAGULASE WITH THE
COMPONENTS OF HUMAN PLASMA*
MORRIS TAGER
Among the diverse views which have been advanced to explain the
mechanism of the clotting of blood by staphylocoagulase, it has been
suggested that coagulase acts directly on fibrinogen,4"3 or that it is
a proteolytic enzyme,3 similar to trypsin, which activates prothrombin.
Recently,however,theenzymicnatureofcoagulasehasbeenquestioned.12
Smith and Hale,' in a significant contribution, brought forth evidence
that an "activator" is present in plasma, and suggested that coagulase
itself is a prothrombin-like substance which reacts with the specific
activator to form a thrombin-like product which, in turn, reacts with
fibrinogen. In a subsequent study,10 however, they proposed an alterna-
tive hypothesis, namely, that coagulase is the activator or kinase, while
the substance in plasma, previously called "activator," might be
prothrombin-like in nature.t
The critical experiment which led Smith and Hale' to conclude that
coagulase does not act directly on fibrinogen depended on the procedure
of precipitating dilute plasma at a pH of 5.3, as developed by Mellanby'
for the purification of prothrombin. In the hands of the British in-
vestigators, this procedure led to a dissociation of fibrinogen from the
plasma factor, since such preparations, containing fibrinogen, lacked the
coagulase-reacting factor.
TheMellanby precipitatecontains mostof thecomponents ofplasma
which partake in the coagulation of blood, and it therefore appeared of
particular interest that C.R.F. was not demonstrable in such a prepara-
tion. It raised the problem of attempting to determine the plasma
components which possess this activity. As the first step, therefore, in
defining more completely the coagulase-plasma interaction, studies were
undertaken to identify the plasma fractions which react with coagulase.
* From the Department of Bacteriology, Yale University School of Medicine. Aided
by a grant from the Navy Department, Office of Naval Research, and by a grant from
the Fluid Research Fund of Yale University School of Medicine.
t Since the precise mechanism of coagulase-plasma interaction is not yet established,
the term "activator" will be avoided, and the agent with which coagulase reacts will
be referred to as the coagulase-reacting factor (C.R.F.).370 YALE JOURNAL OF BIOLOGY AND MEDICINE
Materials and methods
Staphylocoagulase: Various purified preparations of coagulase were used, all
derived from a single strain of hemolytic Staphylococcus aureus No. 104 isolated
from a cutaneous abscess. The titers of these preparations varied from 1:10,240
to 1:1,200,000. The determination of titer and the standardization of plasma
have been previously detailed.11 It should be stressed that fresh pipettes were
used for each dilution, and that the diluent was a 2 per cent peptone-saline
solution containing 1:5000 merthiolate.
Fibrinogen: Lyophiled bovine fibrinogen (Armour) was made up to contain
280 mg.% in physiological saline, although lower concentrations were at times
employed. The fibrinogen contained a slight trace of C.R.F. which did not
materially interfere with the tests, unless excessively potent coagulase was used.
Plasma fractionation: Mellanby procedure.5 To a given volume of human
citrated plasma, 15 volumes of distilled water were added, and the pH was
adjusted to 5.3 (Beckman pH meter) with dilute acetic acid. Precipitation was
allowed to proceed in the cold for from 3 to 6 hours. At this time, the pre-
cipitate was harvested by decanting the supernatant and by centrifugation. It
was then brought into solution in physiological saline at a pH of 7.3 or in M/15
phosphate buffers at the same pH.
Ammonium sulfate precipitation: Three techniques were used.
1. Taking 70.6 grams per cent as saturation, plasma was treated by 50 per
cent saturation with ammonium sulfate. The supernatant solution was then
dialyzed against water, in the cold (4°C.) and constituted the albumin fraction,
which was then lyophilized. The precipitate was dissolved in saline, and then
dialyzed against distilled water. The precipitate which resulted was dissolved
in saline, and constituted principally the "euglobulin" fraction. The supernatant
solution was then the "pseudoglobulin" component. The globulins were
lyophilized if not used immediately.
2. To a given volume of plasma, a saturated solution of ammonium sulfate
was added to a final concentration of 33 per cent. After overnight refrigeration,
the precipitate was separated and resuspended in saline at a pH of 7.0. To the
clear supernatant, ammonium sulfate was added to bring the final concentration
to 50 per cent saturation, and again after overnight refrigeration, the precipitate
was dissolved in saline at neutral pH.
3. The method as described by McMeekin5 was followed. The plasma was
diluted with an equal volume of water adjusted to a pH of 6.0 and increments
of ammonium sulfate were introduced by placing the appropriate quantities in
a cellophane bag. The membranes were rotated for 48 hours at 4°C. for each
sample, and precipitates of plasma were separated at 33, 40, 45, and 50 per
cent saturation with ammonium sulfate, respectively. The precipitates were
washed with the corresponding concentration of ammonium sulfate, dissolved in
saline to the original plasma volume, and the pH brought back to neutrality.PLASMA COMPONENTS REACTING WITH STAPHYLOCOAGULASE 371
Ethanol plasma fractions:* These fractions were prepared by ethanol pre-
cipitation under rigidly controlled conditions of temperature, ionic strength,
alcohol concentration, protein content, and pH.'
Blood-clotting tests: Prothrombin, thromboplastin, and other determinations
relevant to blood dotting were generally carried out essentially as recommended
byQuick.8
Titration of plasma and of plasma fractions: A master set of serial doubling
dilutions of coagulase was first prepared. These coagulase dilutions were then
dispensed to the required number of identical series of tubes, using a different
pipette for each dilution. Each tube contained 0.5 ml. of coagulase in 2 per
cent peptone-saline containing 1:5000 merthiolate. To each tube of the first
set of coagulase dilutions were added 0.5 ml. of undiluted plasma or of the
respective plasma fractions. The succeeding sets of identical coagulase dilutions
received one of 10-fold dilutions of plasma or of the fractions, although inter-
mediate dilutions were at times determined. Each tube then received 0.5 ml. of
freshly dissolved fibrinogen (bovine, Armour), the stock solution usually con-
taining 280 mg.%. The total volume of each tube was therefore 1.5 ml. After
mixing, the tubes were incubated at 37'C. in a water bath, and the course of the
reaction followed by readings at intervals to 24 hours. The firmness of the
clot was recorded on the basis of 4-plus for a solid coagulum to plus-minus for
the slightest trace. The following controls were incorporated in each test:
1. coagulase dilutions plus fibrinogen, with saline in place of plasma or
plasma fractions;
2. each dilution of plasma or of plasma fractions plus fibrinogen, with 2
per cent merthiolated peptone-saline in place of coagulase;
3. at times blanks of fibrinogen alone, or of plasma, or of the plasma fractions
alone were included. Ordinarily, however, these were not necessary, since any
aberration in these reagents would have become immediately apparent from
the disturbance of the progression of the reaction in the test.
Salts, pH: Fibrinogen and plasma dilutions were made up in 0.85 per cent
saline without adjustment of pH. However, titrations were also carried out in
M/15 phosphate buffers at a pH of 7.3 as well as in veronal buffer at the same
pH. The results did not significantly differ from those obtained with unbuffered
saline.
Results
Acid precipitation of plasma by the Mellanby technique: Contrary
to the findings of Smith and Hale,9 the C.R.F. was repeatedly demon-
strated in the moiety brought down by the precipitation of dilute
plasma at a pH of 5.3. It will be noted (Table 1) that the C.R.F. titer
of the globulin precipitate differed little from that of the parent plasma,
attaining a dilution of i0-5 in both instances at 20 hours. The clotting
* These fractions were kindly supplied by the Department of Physical Chemistry of
the Harvard Medical School. The products of plasma fractionation were developed from
blood collected by the American Red Cross, by the Department of Physical Chemistry,
Harvard Medical School, Boston, Mass., under a contract, recommended by the Committee
on Medical Research, between the Office of Scientific Research and Development and
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Table 1
COAGULASE-REACTING FACTOR IN MELLANBY PRECIPITATE OF PLASMA
Plasma, coag.
dilutions,
fibrinogent TIME
Plasma dilutions 15 min. 30min. 60min. 5 hrs. 20hrs.
Undiluted plasma 4x4,20 4x5,20 4x6,1 4xlo 4xlo:
10-1 4x4,0 4x5,0 4x6 4x9,2 4x10
10-2 4x3,20 4x4,20 4x5,2 4x7,221 4xlo
10-3 4420 4x4,0 4x4,31 4x6,2 4x832
10-4 0 0 442 4x5,j 4x5,33221
10-5 0 0 0 1110 333321
Undil. Mellanby ppt. 4x4,1 4x6,0 4x8,1 4xlo 4xlo
10-1 4421 44332 4x6 4x9,3 4xlo
10-2 2332 23432 33,4x4 2x4x7,21 4xlO
10-3 22 233 33444 3x4x7,2 4x832
10-4 0 0 0 4x5,1 4x7,322
10-5 0 0 0 0 33221
Coag. + fibrinogen 0 0 0 0 1
Plasma dil. + fibr. 0 0 0 0 0
Undil. Mellanby ppt.
+ fibrinogen 0 0 0 4 4
Mellanby ppt. 10-1
+ fibrinogen 0 0 0 0 4
All other Mellanby ppt. dilutions remain negative throughout.
* Coagulase: Numbers refer to firmness of clot. Position of figure represents dilution
of coagulase (e.g., "2,4x7,21" means a 2-plus clot in the first tube, coagulase 1:30, 4-plus
in the following 7 doubling dilutions, 2-plus in the 8th tube, etc.).
tFibrinogen: 280 mg. per cent.
t Titrations not carried beyond the 10th tube.
of the globulin controls in the undiluted range and at a dilution of 10-1
at 5 and at 20 hours does not interfere with the reading of the test
before those times at these dilutions, nor with the higher dilutions of the
globulin at any time, since the controls for these remained negative.
The reaction was faster at the undiluted and the 101 levels with the
globulin than with the parent plasma, suggesting the possibility that
the procedure removed an inhibitor.
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Ammonium sulfate fractionation: Since the Mellanby precipitate
is a complex mixture of fibrinogen, prothrombin, cholesterol, pigments,
etc., the presence of the C.R.F. in this material suggested further ex-
ploration of the plasma globulins. Ammonium sulfate fractionation
was therefore undertaken according to the three schemes previously out-
lined. The results obtainedwith the different techniques were in essential
agreement. Table 2 summarizes the findings of one experiment in which
ammonium sulfate was slowly added to the plasma through rotating
cellophanemembranes. To insure more accurateend-points, the dilutions
examined beyond 1:10,000 were the following: 1:20,000, 1:40,000,
1:80,000, and 1:120,000. The sample obtained by 45 per cent satura-
tion showed maximal recovery of the C.R.F. It will be noted that the
total yield ofthe fractions exceeds slightly the titer of the parent plasma.
If additional fractions had been tested, in the zone of albumin precipita-
tion, it is entirely likely that a further small increment of C.R.F. would
have been recovered, as, indeed, had been the case in other ammonium
sulfate runs. It may well be that the fractionation procedure effects a
release of the activity, allowing higher yields than were obtained with
the native plasma.
Table 2
THE COAGULASE-REACTING FACTOR IN AMMONIUM SULFATE PRECIPITATES OF PLASMA
Fraction Reciprocal of titer at 24 hrs. Per cent of plasma titer
Whole plasma 120,000 100.0
33% A. S.* 20,000 16.6
40% A. S. 1,000 0.8
45% A. S. 80,000 66.6
50% A. S. 20,000 16.6
A. S. = ammonium sulfate saturation.
Ethanol fractions: The availability of the many components of
plasma prepared under the auspices of the Department of Physical
Chemistry of the Harvard Medical School offered an opportunity for
a more precise localization of the C.R.F. Table 3 lists the fractions em-
ployed and gives other pertinent data.
Since the Mellanby procedure failed to dissociate fibrinogen from
C.R.F., attention was first directed to Fraction I. Crude Fraction I was
found to possess considerable C.R.F. Therefore, a greatly purified sub-
fraction, as well as the non-clottable residue, was also tested. It will be
noted (Table 4) that the technique of serial dilution of the fractions,
discloses that a very considerable loss of C.R.F. occurs when fibrinogenYALE JOURNAL OF BIOLOGY AND MEDICINE
is purified, but that this activity is retained by the non-clottable residue.
Thus, while the activity of the non-clottable fraction is all but identical
to that of the crude fibrinogen, the purified fibrinogen possesses only
Table 3
ETHANOL-PRECIPITATED HUMAN PLASMA FRACTIONS
Appr. amt.
Plasma fraction Amt. used inplasma
lotnumber Principal components gm./l. gm./l.t
I (IT 464C) crude fibrinogen-55% protein 3.5 3.0
I (162 I-2) 57% pur. fibrinogen; 86% clottable;
65% protein 3.5 2.0
I (N-C) non-clottable residue of I 3.5
II (AVL 36-39; 49-57) v globulin 6.0 6.0
III-0 (171-a) pi globulin solution (25x plasma) 1:25 dilution
III-1 (S 362-4) ,2 globulin 0.65 2.0
III-22f (Lederle 421L-F) prothrombin, thrombin
(82% Pi, 9% fl2) 0.65 2.0
III-3-1 (Squibb I) plasminogen 0.65
IV-1 (AVL 29-35) ax glob., lipids 4.5 5.0
IV-4 (AVL 29-35) a and j3 glob. 4.5 4.5
V (AVL 36-39) albumin 30.0 32.0
* The amount of plasma fraction used in a volume of 0.5 ml. in the undiluted sets
of Table 4 and Table 5.
t Derived from legend on samples furnished, and from data of Dr. John T. Edsall:
"The plasma proteins and their fractionation." Advances in Protein Chemistry,
Academic Press, New York, 1947.
Fraction III-0 furnished as a solution 25x the content of plasma; all other fractions
obtained as lyophiled powders.
Fraction I contained about 40 per cent of salt by weight, while the salt content of the
other fractions was under 5 per cent.
about 0.2 per cent of this activity. This evidence certainly supports the
conclusion that C.R.F. and fibrinogen are distinct.
Since adissociation ofC.R.F. fromfibrinogen was established (Table
4), the other ethanol fractions were studied. It should be noted that the
titrations of the fibrinogen fractions, as well as of the other plasma com-
ponents (Table 5), were carried out with the same preparations of
coagulase and of fibrinogen. This coagulase clotted a standardized
plasma in a dilution of 1:20,480, but the coagulase dilutions in the test
were not carried to the end-point. The procedure differed from previous
titrations in that M/15 phosphate buffer at a pH of 7.3 was used to
dilute theplasmafractions and thefibrinogen, and the latter was reduced
to 200 mg.%. With the exception of Fraction V, all samples possessed
some C.R.F. A further correction factor must be applied, since the
presence of thrombin in some of the fractions, and the consequent
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Table 4
COAGULASE-REACTING FACTOR AND FRACTION I OF HUMAN PLASMA.
Coagulase+
bovinefibrinogen+
Crude I TIME
Crude I dilutions 15 min. 30 min. 1 hr. 3 hrs. 20hrs.
undiluted 480 720 1440 3840 3840
10-1 180 480 1440 3840 3840
10-2 0 90 360 2880 3840
10-3 0 0 0 90 3840
5x16-8 0 0 0 0 360
10-i 0 0 0 0 0
Purified I dilutions
undiluted 0 45 1440 3840 3840
10-1 0 0 0 30 3840
10-2 0 0 0 0 0
10-i 0 0 0 0 0
Non-clottable residue of I
dilutions
undiluted 360 960 1920 3840 3840
10-1 180 360 960 3840 3840
10-2 0 0 90 1440 3840
10-s 0 0 0 0 1440
5x10-3 0 0 0 0 90
10-4 0 0 0 0 0
Coagulase +
bovine fibrinogen 0 0 0 0 0
Bovine fibrinogen (Armour), 280 mg.% added to all tubes of test except undiluted
crude I and purified I.
Coagulase expressed as reciprocal of titer; not carried beyond 3840.
Controls of all test fractions plus fibrinogen negative, except for + in the undiluted
set of the non-clottable residue.
clotting of controls, necessitated the use of initial amounts considerably
below that of plasma. When these corrections are applied (Table 6)
the most active fractions are III-1, III-2, and IV-1.
The association of C.R.F. with various plasma fractions does not
necessarily establish its identity with the proteins; it might be lipoidal
in nature. To test this possibility, titrations were carried out with
cholesterol and lecithin, but these failed to show any significant activity.
Further, plasma was extracted with 3 volumes of petroleum ether for
a period of 6 hours. The ether layer was removed from the separatory
funnel and evaporated to dryness. The reconstituted material possessed
no significant activity. The remainder of the plasma retained most of
the C.R.F., although some deterioration was noted. No evidence, there-376 YALE JOURNAL OF BIOLOGY AND MEDICINE
Table 5
COAGULASE-REACTING FACTOR IN ETHANOL FRACTIONS OF HUMAN PLASMA
Coagulase fibrinogeent TIME
+ fraction 15 min. 30 min. 60min. 180 min. 20hts.
II, undiluted 480 480 960 1920 3840
10-1 0 180 720 1920 3840
10-2 0 0 0 0 0
III-0 undiluted 480 960 1920 3840 3840
10-1 0 360 960 3840 3840
10-2 0 0 0 180 3840
10-3 0 0 0 0 0
III-1, undiluted 1440 3840 3840 3840 3840*
10-1 720 1440 3840 3840 3840
10-2 0 720 1440 3840 3840
10- 0 0 0 0 2880
5x10-3 0 0 0 0 90
10-4 0 0 0 0 0
III-2-2f, undiluted 3840 3840 3840 3840 3840*
10-1 2880 3840 3840 3840 3840
10-2 180 720 1440 3840 3840
10-8 0 0 0 360 2880
5x10-3 0 0 0 0 90
10-4 0 0 0 0 0
III-3-1, undiluted 3840 complete lysis
10-1 3840 3840 3840 3840 3840
10-2 0 0 0 480 3840
10-s 0 0 0 0 10
IV-1, undiluted 480 960 1920 3840 3840
10-1 360 720 1920 3840 3840
10-2 45 180 720 2880 3840
10-3 0 0 0 360 3840
5x104 0 0 0 0 1440
104 0 0 0 0 30
IV-4, undiluted 45 360 960 3840 3840
10-' 0 0 0 1440 3840
10-2 0 0 0 0 180
10-3 0 0 0 0 0
V, undiluted 0 0 0 0 0
10-1 0 0 0 0 0
Coag. + fibrinogen 0 0 0 0 0
Plasma fractions + fibrinogen:
II, III-0, IV-1, IV-4, and V negative throughout.
III-1: positive, undiluted at 30', 10-1 at 20 hrs. All others negative.
III-2: positive, undiluted at 5', 10-1 at 15', 10-2 at 20 hrs. All others negative.
III-3-1: positive, undiluted, with secondary lysis; 10-1 at 15', 10-2 at 20 hrs. All
others negative.
* Lysis at 20 hrs.
tFibrinogen, bovine (Armour) 280 mg.% in saline.
Fractions diluted in M/15 phosphate buffer at pH 7.3.
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Table 6
TITERS OF ETHANOL PRECIPITATED PLASMA FRACTIONS REACTING WITH COAGULASE
Plasma fraction Titer (reciprocal) Corrected titer (reciprocal)
Crude I 5000 9000*
Purified I 10
Non-dotable I 5000 9000t
II 10
III-O 100
III-1 5000 15,000:
III-2-2f 5000 15,000:
III-3-1 100
IV-1 10,000
IV-4 100
V 0
See data ofTables 4 and 5.
t Corrected for high salt content.
4: The initial concentration used was one-third that of the content of plasma.
fore, was forthcoming in favor of a free lipoid functioning as the C.R.F.
C.R.F. might be a smaller molecule, perhaps even a trace ion carried
down with the proteins. Therefore the effects of ultrafiltration and of
dialysis were tested. When a sample of plasma was subjected to ultra-
filtration (Table 7), using the method of Danowski,2 only 1 per cent
of the activity passed through the membrane. Comparable results were
obtained with natural ultrafiltrates, such as normal spinal fluid. Since
the membranes are not totally impervious to proteins, precipitation
with 10 per cent trichloracetic acid was carried out. The C.R.F. of the
ultrafiltrates was largely recovered from reconstituted trichloracetic
acid precipitates.
Various plasma samples were then subjected to prolonged dialysis,
up to five days against saline, or against many changes of distilled water.
After volume corrections were made, and globulin precipitates resulting
from dialysis against water were redissolved, no significant loss of
C.R.F. was evident. These findings, coupled with those of ultrafiltration,
as well as the loss of activity on heating, fail to support the hypothesis
thatthe C.R.F. might represent some trace ion or free, smaller molecule.
Discussion
By means of coagulase preparations of high potency, and of serial
plasma fraction dilution, evidence has been obtained regarding the
possible nature and localization of the coagulase-reacting factor. The
technique of serial coagulase dilution simultaneously with serial plasmaYALE JOURNAL OF BIOLOGY AND MEDICINE
dilutionproved indispensable, since completely misleading results would
follow from databased on serial coagulase dilution against a single level
of plasma or plasma fraction. For example, the behavior of crude and
of purified fibrinogen, when undiluted, was not strikingly different, al-
though the latter reacted less rapidly with the same dilutions of
coagulase. When, however, serial dilutions of these reagents were
Table 7
COAGULASE-REACTING FACTOR IN CELLOPHANE ULTRAFILTRATE OF PLASMA
Coagulase + fibrinogen +
plasma insidebag Time
Dilutions of plasma 15 min. 30 min. 60 min. 180 min. 20his.
undiluted 45 90 720 720 2880
10-1 15 90 960 960 2880
10-2 0 60 480 480 2880
10-3 0 30 240 240 360
104 0 0 90 90 180
10-5 0 0 0 0 90
5xlO-5 0 0 0 0 15
Coagulase + fibrinogen +
dilutions of usIrailtrate
undiluted 0 15 45 120 1440
10-1 0 0 0 90 720
10-2 0 0 0 0 90
10-3 0 0 0 0 30
10-4 0 0 0 0 15
Coagulase + fibrinogen 0 0 0 0 15
Bovine fibrinogen 280 mg.%.
Coagulase expressed as reciprocal of titer.
Controls of the ultrafiltrate and of the plasma within the cellophane bag, when
reacted with fibrinogen in the absence of coagulase, negative throughout.
tested, it became clear that the purified fibrinogen retained only about
0.2 per cent of the C.R.F. of the cruder sample. Furthermore, it became
possible to demonstrate that the C.R.F. was almost quantitatively re-
covered in the non-clottable residue of Fraction I, indicating that its loss
inthe purer fibrinogen did not represent denaturation, but resulted from
chemical separation. The serial dilution technique also made it evident
that the maximal concentration of C.R.F. was in Fractions III-1, 111-2,
and IV-1, while the scatter among other fractions reflected widely
different, and often slight, titers of activity.
The results obtained with the different fractionation techniques are
mutually complementary. Best quantitative yields were attained by the
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Mellanby procedure and by ammonium sulfate precipitation. Although
the latter procedure showed excellent recovery of C.R.F. in the fraction
brought down by 33 to 50 per cent saturation, it failed to eliminate
entirely the C.R.F. from other components, notably the supernatant
solution after the precipitate following 50 per cent saturation was re-
moved. This solution contains albumin, and failure to obtain clear-cut
separation of the C.R.F. from fibrinogen and from albumin was also
experienced by Pijoan7 when ammonium sulfate precipitation was
applied. By means of the ethanol fractions, however, it has been
possible to eliminate both fibrinogen and albumin as the reacting sub-
stances, butthe scatter amongthe other fractions was too great to permit
quantitative recovery in any one component.
While the claims of Smith and Hale in regard to the existence of a
factor in plasma which reacts with coagulase have been confirmed, the
failure of these observers to demonstrate the C.R.F. in the globulin
complex precipitated by the Mellanby technique, remains puzzling.
Possibly lytic or inhibitory agents masked the coagulase-reacting factor
in theirpreparations.
The relation of C.R.F. to the blood clotting components of plasma
will be further considered in another paper now in press.
Summary
1. Thelocalizationofthecoagulase-reactingfactorin human plasma
has been studied by a variety of techniques.
2. Maximal recovery was obtained in association with globulin
fractions obtained by precipitation with ammonium sulfate between
33 and 50 per cent saturation, as well as by acid precipitation of a
diluted plasma at a pH of 5.3.
3. Fractions obtained by ethanol precipitation showed maximal
titers in IJI-1, III-2, and IV-1.
4. C.R.F. is not fibrinogen, since purification of crude Fraction I
results in its recovery in the non-clottable residue.
5. Albumin (Fraction V) is devoid of the C.R.F.
6. No evidence was found to indicate that free lipoids or trace ions
exert any critical effect.
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